Could a Baby-Friendly ivermectin formula beat scabies?

NCT ID NCT06918665

Terminated Knowledge-focused Sponsor: Murdoch Childrens Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This trial compares a new ivermectin powder mixed with infant formula to the standard tablet in 52 healthy adults. The goal is to see if the new formulation is absorbed similarly, tastes better, and causes no new side effects. Results will guide future use in children with scabies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ivermectin
What this could lead to: If successful, this could lead to a more palatable ivermectin formulation for children, making scabies treatment easier.
What could go wrong: This is a small, early-phase trial in healthy adults, not children. The new formulation may not prove bioequivalent or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCABIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

scabies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCABIES

Contacts and locations

Locations

The Royal Children's Hospital

Melbourne, Victoria, 3016, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.